Vote — Oct 9, 2015 1:24 p.m.
Jun 26, 2007
110th Congress, 2007–2009
This bill was introduced on June 27, 2007, in a previous session of Congress, but was not enacted.
Senator from Massachusetts
Read Text »
Last Updated: Nov 19, 2008
Length: 88 pages
A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes.
Biologics Price Competition and Innovation Act of 2007 - Amends the Public Health Service Act to allow a person to submit an application for licensure of a biological product based ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
Reported by Committee
A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 1695”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 1695 — 110th Congress: Biologics Price Competition and Innovation Act of 2007. Retrieved from https://www.govtrack.us/congress/bills/110/s1695
“S. 1695 — 110th Congress: Biologics Price Competition and Innovation Act of 2007.” www.GovTrack.us. 2007. October 10, 2015 <https://www.govtrack.us/congress/bills/110/s1695>
|title=S. 1695 (110th)
|accessdate=October 10, 2015
|author=110th Congress (2007)
|date=June 26, 2007
|quote=Biologics Price Competition and Innovation Act of 2007